OSSIO
Brandon Gebhardt is a seasoned Medical Device Sales Representative with extensive experience in the medical technology industry. Currently working with Kolosis BIO since July 2023, Brandon has also held roles at Tenex Health, where minimally invasive technologies for chronic tendon pain treatments are offered, and OSSIO, which focuses on providing credible replacements for metal fixation implants. Previous positions include significant contributions at Novastep USA as a representative for the leading MIS Bunion Company, and at MiMedx, where efforts were centered on placental-based wound care solutions. Brandon's career began with Stryker and included a role at Paragon 28. Brandon holds a Bachelor of Business Administration in Marketing from Florida Atlantic University.
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.